What Inovio Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 34 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 179,021 |
| Disposed | 0 | 75,727 |
| Net activity | +0 | +103,294 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sumner Michael John | Chief Medical Officer | May 20 | Withheld — tax / exercise cost · F | −2,693 | $1.23 | −$3.31K | 42,038 |
| Sumner Michael John | Chief Medical Officer | May 20 | Exercise / conversion · M | +9,450 | — | — | 44,731 |
| Shea Jacqueline Elizabeth | Chief Executive Officer | May 20 | Withheld — tax / exercise cost · F | −12,306 | $1.23 | −$15.1K | 111,021 |
| Shea Jacqueline Elizabeth | Chief Executive Officer | May 20 | Exercise / conversion · M | +28,296 | — | — | 123,327 |
| Kies Peter | CFO | May 20 | Withheld — tax / exercise cost · F | −4,688 | $1.23 | −$5.77K | 42,854 |
| Kies Peter | CFO | May 20 | Exercise / conversion · M | +8,700 | — | — | 47,542 |
| Humeau Laurent | Chief Scientific Officer | May 20 | Withheld — tax / exercise cost · F | −2,163 | $1.23 | −$2.66K | 46,823 |
| Humeau Laurent | Chief Scientific Officer | May 20 | Exercise / conversion · M | +6,027 | — | — | 48,986 |
| Sumner Michael John | Chief Medical Officer | May 15 | Withheld — tax / exercise cost · F | −680 | $1.30 | −$884 | 35,281 |
| Sumner Michael John | Chief Medical Officer | May 15 | Exercise / conversion · M | +2,385 | — | — | 35,961 |
| Kies Peter | CFO | May 15 | Withheld — tax / exercise cost · F | −2,571 | $1.30 | −$3.34K | 38,842 |
| Kies Peter | CFO | May 15 | Exercise / conversion · M | +4,771 | — | — | 41,413 |
| Humeau Laurent | Chief Scientific Officer | May 15 | Withheld — tax / exercise cost · F | −1,712 | $1.30 | −$2.23K | 42,959 |
| Humeau Laurent | Chief Scientific Officer | May 15 | Exercise / conversion · M | +4,771 | — | — | 44,671 |
| Shea Jacqueline Elizabeth | Chief Executive Officer | May 15 | Withheld — tax / exercise cost · F | −7,717 | $1.30 | −$10K | 95,031 |
| Shea Jacqueline Elizabeth | Chief Executive Officer | May 15 | Exercise / conversion · M | +17,744 | — | — | 102,748 |
| Sumner Michael John | Chief Medical Officer | Mar 31 | Withheld — tax / exercise cost · F | −1,223 | $1.74 | −$2.13K | 33,576 |
| Sumner Michael John | Chief Medical Officer | Mar 31 | Exercise / conversion · M | +4,292 | — | — | 34,799 |
| Weiner David B. | Director | Feb 26 | Exercise / conversion · M | +972 | — | — | 87,592 |
| Sumner Michael John | Chief Medical Officer | Feb 26 | Withheld — tax / exercise cost · F | −3,903 | $1.79 | −$6.99K | 30,507 |
Loading...